Cefpodoxime-proxetil hydrolysis and food effects in the intestinal lumen before absorption: In vitro comparison of rabbit and human material

International Journal of Pharmaceutics

Volumn 157, Issue 2, 1997, Pages 153-161

  Crauste Manciet, Sylvie ^a   Decroix, Marie Odile ^a   Farinotti, Robert ^b   Chaumeil, Jean Claude ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Absorption; Amino acids; Cefpodoxime proxetil; Cholinesterase; Human duodenal washing; Lipid; Trace elements; Vitamins

Indexed keywords

CEFPODOXIME;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; ESTERIFICATION; FOOD INTAKE; HUMAN; HYDROLYSIS; INTESTINE ABSORPTION; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030735181     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00227-5     Document Type: Article

References (36)

1. Aldridge W.N. Serum esterase. 1. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. Biochem. J. 53:1953;110-117.
2. Ali B., Kaur S. Mammalian tissue acetylsalicylic acid esterase: identification, distribution and discrimination from other esterase. J. Pharmacol. Exp. Ther. 226:1983;589-594.
3. Augustinsson K.B. Multiple forms of esterase in vertebrate blood plasma. Ann. N.Y. Acad. Sci. 94:1961;844-860.
4. Bergmann F., Wilson I.B., Nachmansohn D. Acetylcholinesterase. IX Structural features determining the inhibition by amino acids and related compounds. J. Biol. Chem. 186:1950;693-703.
5. Billiar R.B., Eik-Nes K.B. Use of cholinesterase for hydrolysis of steroid acetate. Anal. Biochem. 13:1965;11-18.
6. Blouin R.A., Kneer J., Ambros R.J., Stoeckel K. Influence of antiacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Antimicrob. Agents Chemother. 34:1990;1744-1748.
7. Borin M.T. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs. 42:1991;13-21.
8. Borin M.T., Forbes K.K. Effect of food on absorption of cefpodoxime-proxetil oral suspension in adults. Antimicrob. Agents Chemother. 39:1995;273-275.
9. Borin M.T., Forbes K.K., Hughes G.S. The bioavailability of cefpodoxime-proxetil tablets relative to an oral solution. Biopharm. Drug Dispos. 16:1995;295-302.
10. Borin M.T., Driver M.A., Forbes K.K. Effect of timing of food on absorption of cefpodoxime-proxetil. J. Clin. Pharmacol. 35:1995;505-509.
11. Campbell C.J., Chantrell L.J., Eastmond R. Purification and partial characterization of rat intestinal cefuroxime axetil esterase. Biochem. Pharmacol. 36:1987;2317-2324.
12. Cimasoni G. Inhibition of cholinesterases by fluoride in vitro. Biochem. J. 99:1966;133-137.
13. Crauste-Manciet S., Huneau J.F., Decroix M.O., Tome D., Farinotti R., Chaumeil J.C. Cefpodoxime proxetil esterase activity in rabbit small intestine: a role in the partial cefpodoxime absorption. Int. J Pharm. 149:1997;241-249.
14. Ducharme M.P., Edwards D.J., McNamara P.J., Stoeckel K. Bioavailibility of syrup and tablet formulations of cefetamet pivoxil. Antimicrob. Agents Chemother. 37:1993;2706-2709.
15. Ekholm M., Konschin H. Semi-empirical molecular orbital calculations on bambuterol, an inhibitor of human butyrylcholinesterase. J. Mol. Struct. 314:1994;277-285.
16. Ellman G. L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1:1961;88-95.
17. Finn A., Straughn A., Meyer M., Chubb J. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm. Drug Dispos. 8:1987;519-526.
18. Ginsburg C.M., McCracken G.H., Petruska M., Olson K. Pharmacokinetics and bacterial activity of cefuroxime axetil. Antimicrob. Agents Chemother. 28:1985;504-507.
19. Hughes G.S., Heald D.L., Barker K.B.et al. The effect of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Clin. Pharmacol. Ther. 46:1989;674-685.
20. Inoue M., Morikawa M., Tsuboi M., Yamada T., Sugiura M. Species difference and characterisation of intestinal esterase on the hydrolizing activity of ester-type drugs. Jpn. J. Pharmacol. 29:1979;9-16.
21. Inoue M., Morikawa M., Tsuboi M., Yamada T., Sugiura M. Hydrolysis of ester-type drugs by the purified esterase from human intestinal mucosa. Jpn. J. Pharmacol. 29:1979;17-25.
22. Iwanaga Y., Kimura T., Miyashita N.et al. Characterization of acetylcholinesterase-inhibition by itopride. Jpn. J. Pharmacol. 66:1994;317-322.
23. La Du, B.N., Snady, H., 1971. Esterase of human tissues. In: Brodie, B.B., Gilette, J.R. (Eds.), Handbook of Experimental Pharmacology - Concepts in Biochemical Pharmacology, 28, vol. 2. 1971, Springer, Berlin, pp. 477-499.
24. Martinvalmaseda E.M., Sanchezyague J., Cabezas J.A., Llanillo M. Biochemical characterization of sheep platelet acetylcholinesterase after detergent solubilization. Comp. Biochem. Physiol. B. 110:1995;91-101.
25. Maruzek M., Witkiewiecz Z. The determination of trace quantities of organophosphorus warefare agents by enzymatic method in thin layer chromatography. Chem. Anal. 40:1995;531-542.
26. Morikawa M., Inoue M., Tsuboi M., Sugiura M. Studies on aspirin esterase of human serum. Jpn. J. Pharmacol. 29:1979;581-586.
27. Myers C. Hydrolysis of methylprednisolone acetate by human serum cholinesterase. Drug Metab. Dispos. 10:1982;279-280.
28. Shinkula A.A., Yalkowski S.H. Rationale for design of biologically reversible drug derivatives: prodrugs. J. Pharm. Sci. 64:1975;181-210.
29. Sommers D.E.K., VanWyk M., Moncrieff J., Shoeman H.S. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil. Br. J. Clin. Pharmacol. 18:1984;535-539.
30. Stoytcheva M., Zlatev R. Bioelectrocatalytical studies of the effect of some pharmaceuticals on the acetylcholinesterase activity. Electroanalysis. 8:1996;676-679.
31. Tam Y.K., Kneer J., Dubach U.C., Stoeckel K. Effect of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob. Agents Chemother. 34:1990;1556-1559.
32. Usdin, E., Reaction of cholinesterases with substrate inhibitors and reactivators. In: Karczmar, A.G (Ed.), International Encyclopedia of Pharmacology and Therapeutics. Anticholinesterase Agents, 13, vol. 1. Pergamon Press, Oxford, 1970, pp. 47-354.
33. Walker C.H., Mackness M.I. Esterase: problems of identification and classification. Biochem. Pharmacol. 32:1983;3265-3269.
34. Walker, C.H., The development of an improved system of nomenclature and classification of esterase. In: Reiner, E., Aldridge, W.N., Hoskin, F.C.G. (Eds.), Enzyme Hydrolysis Organophosphorus Compounds. Ellis Horwood, Chichester, 1989, pp. 236-245.
35. White K.N., Hope D.B. Characterization of aspirin of guinea-pig liver cytoplasm. Biochem. Biophys. Acta. 785:1984;132-137.
36. Williams F.M. Clinical significance of esterase in man. Clin. Pharmacokinetics. 10:1985;392-403.